Diabetologia, 60, 15771585
A persistent administration of morphine that targets -opioid receptor downregulates the signal, requiring higher dosage of morphine to elicit the original level of response [1518]
SpaceX Gets the Attention, But These 4 Stocks Could Get the Returns Chapter 1: A GLP-1 Contrarian Play Amylyx is taking the opposite approach to the GLP-1 boom: instead of developing agonists for weight loss, the company is developing a GLP-1 antagonist
If you are looking to start your journey, highly recommended
As a representative example of this advanced in vitro approach, in 2021 Peter Ertls group established a synovium-on-chip platform that leverages patient-derived FLS
At the facility, 120 L of water was added to the samples, which were then sonicated for an additional 15 min